Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody
- 1 August 1997
- journal article
- Published by Elsevier in The Breast
- Vol. 6 (4) , 171-176
- https://doi.org/10.1016/s0960-9776(97)90568-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cell cycle progression and phenotypic modification of Ki67 antigen‐negative G1‐ and G2‐phase cells in phorbol ester‐treated molt‐4 human leukemia cellsCytometry, 1995
- Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomasJournal of Neurosurgery, 1995
- Tumor progression accompanied by increase in proliferation rate in breast cancer: A preliminary reportJournal of Surgical Oncology, 1993
- Heterogeneity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breastZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Proliferation index in various stages of breast cancer determined by ki-67 immunostainingJournal of Surgical Oncology, 1991
- Regional heterogeneity in breast carcinoma: Thymidine labelling index, steroid hormone receptors, dna ploidyInternational Journal of Cancer, 1991
- Comparison of cell growth in different parts of breast cancersHistopathology, 1990
- Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptorEuropean Journal of Cancer and Clinical Oncology, 1984
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983